Laidlaw Downgrades Mast Therapeutics (MSTX) to Neutral
Tweet
Share
E-mailGet Alerts MSTX Hot Sheet
Price: $8.10 -5.48%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Laidlaw downgraded Mast Therapeutics (NYSE: MSTX) from Buy to Neutral.
For an analyst ratings summary and ratings history on Mast Therapeutics click here. For more ratings news on Mast Therapeutics click here.
Shares of Mast Therapeutics closed at $0.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Berenberg Downgrades Inter Parfums (IPAR) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
